Concerns have been raised that treatment with antipsychotic medication might adversely
affect long-term outcomes for people with schizophrenia. The evidence cited for these …

Background: The literature on antipsychotic medication in psychosis lack systematization of
the empirical knowledge base on patients' subjective experiences of using antipsychotic …

This is a report of a joint World Psychiatric Association/International College of
Neuropsychopharmacology (WPA/CINP) workgroup concerning the risk/benefit ratio of …

Purpose Medication has been a central part of treatment for severe mental disorders in
Western medicine since the 1950s. In 2015, Norwegian Health Authorities decided that …

Background: Despite the evidence of the importance of including service users' views on
psychotherapy after psychosis, there is a paucity of research investigating impact on full …

Background Medication-free treatment within mental health care aims to offer therapeutic
support as an alternative to psychotropic medication. Introducing milieu therapy for severely …

People commonly think of the mind and the brain as distinct entities that interact, a view
known as dualism. At the same time, the public widely acknowledges that science attributes …

Purpose To study the impact of supervised antipsychotic medication discontinuation on
clinical and functional outcomes in first-episode psychosis (FEP) in two different cultural …

Antipsychotic medication has been the mainstay of treatment for psychotic illnesses for over
60 years. This has been associated with improvements in positive psychotic symptoms and …

BackgroundDue to the paucity of previous studies, we wanted to elucidate the
pharmacoepidemiology of antipsychotics in schizophrenia in a general population sample …